Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXQC5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,809
Award facts
- Contract value 100% obligated
- $10,809.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,809.06 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL pen injectors. This firm fixed-price, competitively awarded delivery order was issued on December 11, 2025, with an ultimate completion date of December 12, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions, making this a critical pharmaceutical supply for military and federal healthcare beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement extending through December 2026. AmerisourceBergen Drug Corp, a leading pharmaceutical distributor and healthcare solutions provider, maintains an extensive federal contract portfolio with the DLA's Medical Supply Chain, delivering a broad range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic areas. The contract supports critical federal healthcare programs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FXQC5?
SPE2DR26FXQC5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FXQC5 worth?
The government has obligated $10,809 on SPE2DR26FXQC5.
Is contract SPE2DR26FXQC5 an order under another contract?
Yes. SPE2DR26FXQC5 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXQC5 competed?
The extent of competition for SPE2DR26FXQC5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award